Ophthalmology

Ophthalmology

Field of medicine treating eye disorders

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
BioSpace
June 3, 2020
BioSpace
Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage company focused on discovering, developing and commercializing transformative therapies to treat rare and underserved eye diseases, today announced the appointment of Dr. Mohamed Genead as chair of the Ocugen, Inc. Retina Scientific Advisory Board, which is comprised of prominent experts who provide strategic advice, clinical and regulatory support, and scientific and industry expertise. Shankar Musu
BioSpace
May 18, 2020
BioSpace
Graybug Vision, Inc., a clinical stage biopharmaceutical company focused on developing transformative medicines to treat vision-threatening diseases of the retina and optic nerve, appoints Parisa Zamiri M.D., Ph.D. as the company's Chief Medical Officer, effective June 1, 2020.
BioSpace
May 15, 2020
BioSpace
Arctic Vision, a clinical stage biotechnology company focusing on the development and commercialization of innovative ophthalmology therapies in China and Asia, announced the formation of its Scientific Advisory Board comprised of three world-class ophthalmologists from China, the United States and the United Kingdom.
Julia Carrie Wong in San Francisco
April 23, 2020
the Guardian
The head of a US government agency for investing in pandemic responses said he was forced out after resisting 'misguided directives' over hydroxychloroquine. Photograph: John Phillips/Getty Images
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.